Alexander Krämer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alexander Krämer has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alf Kastbom
Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
1 shared publication - Amit Saxena
Karolinska Institute 1 Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics Solna, Sweden
1 shared publication - Ana Coelho
Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Solna, Sweden
1 shared publication - Bingze Xu
Karolinska Institute 1 Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics Solna, Sweden
1 shared publication - Christian Michel Beusch
Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, USA
1 shared publication - Christopher Sjöwall
Linköping University
1 shared publication
Latest Publications
- Open Access
- 11 September 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (11)
Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice
B cells undergo several rounds of selection to eliminate potentially pathogenic autoreactive clones, but in contrast to T cells, evidence of positive selection of autoreactive B cells remains moot. Using unique tetramers, we traced natural autoreactive B cells (C1-B) specific for a defined triple-helical epitope on collagen type-II (COL2), constituting a sizeable fraction of the physiological B cell repertoire in mice, rats, and humans. Adoptive transfer of C1-B suppressed arthritis independently of IL10, separating them from IL10-secreting regulatory B cells. Single-cell sequencing revealed an antigen processing and presentation signature, including induced expression of CD72 and CCR7 as surface markers. C1-B presented COL2 to T cells and induced the expansion of regulatory T cells in a contact-dependent manner. CD72 blockade impeded this effect suggesting a new downstream suppressor mechanism that regulates antigen-specific T cell tolerization. Thus, our results indicate that autoreactive antigen-specific naïve B cells tolerize infiltrating T cells against self-antigens to impede the development of tissue-specific autoimmune inflammation.
- 11 September 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (11)
Open AccessAntigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice
B cells undergo several rounds of selection to eliminate potentially pathogenic autoreactive clones, but in contrast to T cells, evidence of positive selection of autoreactive B cells remains moot. Using unique tetramers, we traced natural autoreactive B cells (C1-B) specific for a defined triple-helical epitope on collagen type-II (COL2), constituting a sizeable fraction of the physiological B cell repertoire in mice, rats, and humans. Adoptive transfer of C1-B suppressed arthritis independently of IL10, separating them from IL10-secreting regulatory B cells. Single-cell sequencing revealed an antigen processing and presentation signature, including induced expression of CD72 and CCR7 as surface markers. C1-B presented COL2 to T cells and induced the expansion of regulatory T cells in a contact-dependent manner. CD72 blockade impeded this effect suggesting a new downstream suppressor mechanism that regulates antigen-specific T cell tolerization. Thus, our results indicate that autoreactive antigen-specific naïve B cells tolerize infiltrating T cells against self-antigens to impede the development of tissue-specific autoimmune inflammation.